A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
Clinical trial NCT06764836 · RECRUITING
Trial details
- NCT number
- NCT06764836
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2026-01-27
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.